by Breast reconstruction surgery is increasingly being adopted to restore breast contour and shape following mastectomy procedures performed to treat breast cancer. Various breast reconstruction options allow women to choose implants or autologous tissue flaps to recreate a natural breast form and symmetry. Given the rising incidence of breast cancer worldwide, there is a significant rise in post-mastectomy breast reconstruction procedures. According to the World Cancer Research Fund International, breast cancer is now the most commonly occurring cancer in women worldwide. In 2020, an estimated 2.3 million women were diagnosed with breast cancer globally. The unmet medical needs have resulted in innovative approaches in breast implants, such as 3D-shaped implants and those that offer a more natural appearance and feel.
The global Breast Reconstruction Market is estimated to be valued at US$901.3 Mn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024-2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in breast reconstruction market size is the increasing preference for tissue expansion procedures over implant-based procedures. Tissue expanders are temporarily placed under the chest muscle or chest wall to stretch the skin and make room for a breast implant. This method does not require using tissues from other parts of the body like the DIEP flap method. Furthermore, acellular dermal matrix (ADM) is gaining significant traction in breast reconstruction procedures. The ADM provides additional coverage and support to implants, aids in forming a new breast pocket, and reduces complications. It offers a viable alternative to autologous tissue procedures. Owing to technological advancements, breast reconstruction is increasingly being performed as a single-stage procedure instead of multi-stage surgery, reducing hospital stay and recovery time for patients.
Porter’s Analysis
Threat of new entrants: Low investment requirements for starting aesthetic clinics pose low threat. However, regulatory barriers and strong brand recognition of existing players provide barriers.
Bargaining power of buyers: Buyers have high bargaining power due to availability of substitutes and less differentiation between products. However, initiatives to spread awareness help reduce impact.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to availability of alternative raw material sources and players’ control over distribution.
Threat of new substitutes: Substitutes like tissue expanders, fat grafting procedures pose threats, driving need for innovation.
Competitive rivalry: Intense competition due to large number of players and me-too products. Players focus on quality, innovation and marketing to gain market share.
Key Takeaways
The global Breast Reconstruction Market is expected to witness high growth. The global Breast Reconstruction Market is estimated to be valued at US$901.3 Mn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024-2030.
North America dominates currently due to increasing awareness, favorable reimbursement policies and presence of key players. Asia Pacific region is poised to grow at a CAGR of over 9% during forecast period. Factors such as rising medical tourism, increasing disposable income, growing awareness will drive growth. China dominates APAC due to strong economic growth and healthcare investments.
Key players operating in the Breast Reconstruction market are Polytech Health & Aesthetics GmbH, Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra Inc., GC Aesthetics, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe. Players focus on new product launches, partnerships for geographic expansion and marketing campaigns for brand visibility.
